Article Information
History
- March 27, 2020.
Article Versions
- You are currently viewing Version 1 of this article (March 27, 2020 - 05:12).
- Version 2 (March 30, 2020 - 17:42).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Marjolein F.Q. Kluytmans-van den Bergh1,2,3,*,
- Anton G.M. Buiting4,5,
- Suzan D. Pas6,
- Robbert G. Bentvelsen7,
- Wouter van den Bijllaardt7,
- Anne van Oudheusden5,
- Miranda M.L. van Rijen1,
- Jaco J. Verweij4,
- Marion P.G. Koopmans8 and
- Jan A.J.W. Kluytmans1,3,6
- 1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
- 2Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
- 3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
- 4Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
- 5Department of Infection Control, Elisabeth-TweeSteden Hospital, the Netherlands
- 6Microvida Laboratory for Microbiology, Bravis Hospital, Roosendaal, the Netherlands
- 7Microvida Laboratory for Microbiology, Amphia Hospital, Breda, the Netherlands
- 8Department of Virology, Erasmus Medical Center, Rotterdam, the Netherlands
- ↵*Corresponding author; email: marjoleinkluytmans{at}gmail.com